NIH-funded research R01 grant

Investigating kidney issues caused by Hodgkin's lymphoma

Official title: Hodgkin’s Lymphoma-induced Nephrotic Syndrome

Funded at Rush University Medical Center · NIH-11025226 · Data updated 2026-11-12

This study is looking at how Hodgkin's lymphoma might cause kidney problems called nephrotic syndrome, and it's for patients who have either condition, as researchers want to find new ways to help them feel better.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRush University Medical Center
NIH-funded
Lab location1 site (Chicago, United States)
Project startJanuary 1, 2025
Project endNovember 30, 2029
Funding year2025
Award (this year)$343,650
NIH project number1R01DK141612-01
Project IDNIH-11025226 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include adolescents and young adults diagnosed with Hodgkin's lymphoma who are experiencing symptoms of nephrotic syndrome.

Less likely to help

Patients with Hodgkin's lymphoma who do not develop nephrotic syndrome or those with other unrelated kidney conditions may not benefit from this research.

What this research studies

This research focuses on understanding how Hodgkin's lymphoma can lead to nephrotic syndrome, a serious kidney condition. It examines the role of specific tumor cells that release proteins and cytokines into the bloodstream, which may affect kidney function. The study utilizes advanced techniques, including CRISPR/Cas9 gene editing, to replicate and analyze the genetic changes associated with this condition in laboratory settings. By studying these mechanisms, the research aims to uncover potential therapeutic targets for patients affected by both Hodgkin's lymphoma and nephrotic syndrome.

Why it matters

Potential benefit: If successful, this research could lead to new treatment options for patients suffering from kidney complications related to Hodgkin's lymphoma.

How similar studies have gone: Previous research has shown promising results in understanding the genetic factors involved in kidney diseases related to cancer, suggesting that this approach may yield valuable insights.

Where this research is happening

  • Rush University Medical Center
    Chicago, United States
    Active

Researchers

  • Principal investigator: Molina Jijon, Eduardo — Rush University Medical Center
  • Study coordinator: Molina Jijon, Eduardo

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.